8-KFiling Date: Feb 5, 2026

Bristol Myers (BMY) 8-K: Earnings Release, Reg FD Disclosure (Feb 5, 2026)

bmy-20260205

Event Type

Earnings ReleaseReg FD DisclosureFinancial Statements

Filing overview

Bristol Myers (BMY) filed a Form 8-K (Material Event (8-K)) with the SEC on 2026-02-05. Reported items: Item 2.02 Earnings Release; Item 7.01 Reg FD Disclosure; Item 9.01 Financial Statements.

More filings from Bristol Myers (BMY)

Bristol Myers (BMY) 10-Q · Jul 30, 2026Quarterly Report · ended 2026-06-30 · Rev $13.0B, NI $3.3B
Bristol Myers (BMY) 8-K · Jul 30, 2026Earnings Release; Reg FD Disclosure; Financial Statements
Bristol Myers (BMY) 8-K · May 8, 2026
Bristol Myers (BMY) 10-Q · Apr 30, 2026
Bristol Myers (BMY) 8-K · Apr 30, 2026
Bristol Myers (BMY) 10-K · Feb 11, 2026

Recent 8-K filings from other companies

Nano Nuclear Energy (NNE) 8-K · Oct 2, 2026Material Agreement; Securities Issuance; Reg FD Disclosure; Financial…
Newell Brands (NWL) 8-K · Oct 2, 2026Material Agreement; Financial Obligation; Financial Statements
Quantum Computing (QUBT) 8-K · Oct 2, 2026$1.3B cash, zero debt
Western Union (WU) 8-K · Oct 2, 2026Other Events
Archer Aviation (ACHR) 8-K · Oct 2, 2026Trade-secret claims narrowed in court